Explore the potential implications of biologic disease-modifying antirheumatic drug (bDMARD) molecular structure on placental transfer
Professor Angela Tincani is a senior consultant (previously director) at the Rheumatology and Clinical Immunology Unit of Aziende Socio Sanitaria Territoriali (ASST)-Spedali Civili and University of Brescia, Italy.
Professor Tincani has been involved in several international committees for education and research in the field of systemic autoimmune diseases. Professor Tincani’s primary clinical and research interests include the use of anti-rheumatic drugs in pregnant and lactating patients and the management of pregnancy in rheumatic disease patients, in addition to evaluating autoantibodies and autoimmune diseases as risk factors for poor gestational outcomes. She served as an expert for several European Alliance of Associations for Rheumatology (EULAR) recommendations, including “Points to consider for use of anti-rheumatic drugs before pregnancy and during pregnancy and lactation”. Together with Professor Andreoli, Professor Tincani is co-principal investigator of the “Italian Registry of Pregnancy in Rheumatic Diseases”.
Prof. Prignano and Prof. Liakou discuss patient-reported outcomes, shared decision-making and multidisciplinary HS care
Dr van der Zee and Prof. Arenbergerová explore holistic treatment of HS through medical, surgical and combined approaches
Explore the potential implications of biologic disease-modifying antirheumatic drug (bDMARD) molecular structure on placental transfer
Empower patients with PsA with this interactive guide to help them confidently prepare for appointments and support shared decision-making
Empower patients with axSpA with this interactive guide to help them confidently prepare for appointments and support shared decision-making
Support patients with this wound care guide including practical tips, dressing pros/cons and guidance for routine HS lesions